Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacological control of platelet function.

P Clutton1, J D Folts, J E Freedman

  • 1Departments of Pharmacology and Medicine, Georgetown University Medical Center, Washington, DC, USA.

Pharmacological Research
|October 11, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiometabolic disease in South Asians: A global health concern in an expanding population.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2016
Same author

The role of circulating platelet transcripts.

Journal of thrombosis and haemostasis : JTH·2015
Same author

Platelets: the unsung hero of the immune response.

Journal of thrombosis and haemostasis : JTH·2014
Same author

Streptokinase inhibits acute platelet thrombus formation in stenosed dog coronary arteries.

Platelets·2010
Same author

A new role for the A2b adenosine receptor in regulating platelet function.

Journal of thrombosis and haemostasis : JTH·2010
Same author

NFkappaB regulation of platelet function: no nucleus, no genes, no problem?

Journal of thrombosis and haemostasis : JTH·2009

New anti-platelet drugs have been developed by understanding platelet activation mechanisms and functions. Research into cyclooxygenase, adenosine diphosphate (ADP) receptor, and glycoprotein IIb/IIIa has led to novel drug classes.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Hematology

Background:

  • Platelet activation mechanisms are crucial for hemostasis and thrombosis.
  • Understanding platelet function has driven the development of anti-platelet therapies.
  • Arachidonic acid metabolism and key platelet receptors are central to platelet inhibition.

Purpose of the Study:

  • To review the advancements in understanding platelet activation.
  • To highlight the development of novel anti-platelet drug classes.
  • To discuss future directions in platelet pathway inhibition.

Main Methods:

  • Review of scientific literature on platelet physiology and pharmacology.
  • Analysis of key discoveries in platelet receptor characterization.

Related Experiment Videos

  • Examination of the evolution of anti-platelet drug development.

    • Main Results:

    • Cyclooxygenase inhibitors (e.g., aspirin) emerged from arachidonic acid metabolism studies.
    • Adenosine diphosphate (ADP) receptor and glycoprotein IIb/IIIa antagonists represent novel drug classes.
    • Targeting glycoprotein Ib/IX and signaling pathways are future research avenues.

    Conclusions:

    • Advances in platelet research have significantly expanded anti-platelet treatment options.
    • Targeting specific platelet receptors and pathways offers continued therapeutic innovation.
    • Future drug development will likely focus on more refined inhibition strategies.